Showing results (761-770 of 1,600) with videos related to

Sort By:
Pageof 160
RSC Medicinal Chemistry|September 10, 2026
Development of macrocyclic peptide inhibitors of Mycobacterium tuberculosis MurF via mRNA display with genetic reprogrammingPatrick W Carlos, Charlotte Franck, Caitlin E Clarke-Shepperson, et al.
RSC Medicinal Chemistry|September 3, 2026
Synthesis and structure-activity relationships of small-molecule 2-pyridone based CBX7 inhibitorsChelsea R Wilson, Evan F W Chen, Alok Shaurya, et al.
RSC Medicinal Chemistry|October 2, 2026
Correction: Synthesis, antibacterial activity, and mechanistic characterization of novel 9-substituted berberine derivativesJiaying Tong, Huamao Yang, Yeying He, et al.
RSC Medicinal Chemistry|September 17, 2026
Maslinic acid derivative induces the death of transitional bladder cancer cells through apoptosis and autophagy via the PI3K-AKT signaling pathwayJing-Jing Liu, Li Sun, Dan-Ting Guo, et al.
RSC Medicinal Chemistry|September 24, 2026
Bioactivity studies of organometallic Cp*Rh(iii) and Au(i) NHC complexes bioconjugated to integrin binding peptidesFelix A Böhm, Miriam Caviglia, Bernd Schulz, et al.
RSC Medicinal Chemistry|October 6, 2026
Site-selective acylation of human insulin to engineer a long-acting monovalent insulin-Fc conjugateWanrong Yang, Ruolin Xu, Wanyi Tai
RSC Medicinal Chemistry|October 6, 2026
Relationship between nanoscale assembly and cytotoxicity in the piperazine amides of betulinic acid: an in vitro studyMartina Wimmerová, Miroslav Šlouf, Lucie Rárová, et al.
RSC Medicinal Chemistry|October 14, 2026
Dimercaptosuccinic acid (DMSA) mono-esters and amides: synthesis and application in treating metal induced drug resistance in lung cancerCarissa M Lloyd, Hannah L Richards, Katherine E V Deck, et al.
RSC Medicinal Chemistry|October 14, 2026
Design, synthesis, and structure-activity relationships of novel flavone derivatives as tankyrase inhibitors against colorectal cancerHaiping Yao, Zhu Wang, Nianyu Huang, et al.
RSC Medicinal Chemistry|October 17, 2026
Design, synthesis, and biological evaluation of a novel 1,2,3-triazole-tethered 5-aminosalicylate-metronidazole hybrid as a dual anti-Helicobacter pylori and anti-inflammatory agentHajjaj H M Abdu-Allah, Sasikala Muthusamy, Alshaimaa A B Abdelmoez, et al.
Pageof 160